Retinal photocoagulation laser Smart532™ophthalmicNd:YAGKTP
Add to favorites
Compare this product
Characteristics
- Applications
- ophthalmic, retinal photocoagulation
- Amplifying medium
- Nd:YAG, KTP
- Ergonomics
- tabletop
- Pulse duration
- continuous
- Other characteristics
- subthreshold
- Wavelength
532 nm
Description
Overview
Smart532™ is a retinal photocoagulator by Lumenis integrating SmartPulse™ technology to enable sub-threshold retinal treatment with a green 532 nm laser while limiting collateral tissue effects.
Key features
What is SmartPulse™ Technology?
SmartPulse™ is a tissue-sparing solution that enables sub-threshold retinal treatment by delivering laser energy in a pulsed mode to reduce collateral thermal damage while maintaining therapeutic effect.
SmartPulse™ Mode
SmartPulse™ mode provides clinicians with the capability to perform retinal photocoagulation at sub-threshold settings, offering reduced visible retinal burn and lower collateral effects compared to conventional continuous-wave photocoagulation.
History / Launch
Specifications / technical data
Smart532™ is a retinal photocoagulator by Lumenis integrating SmartPulse™ technology to enable sub-threshold retinal treatment with a green 532 nm laser while limiting collateral tissue effects.
Key features
- Continuous-wave and SmartPulse™ sub-threshold treatment modes
- Advanced laser cavity design for superior stability
- 100% Lumenis Technology
- Exclusive, intuitive user interface with voice confirmation mode
- Compact, lightweight form factor
- Dual-port configuration adapted for clinic workflow
- 25 programmable user pre-sets
- SureSpot™ optics for sharply defined retinal spot and low corneal power density
- Voice confirmation allows the physician to keep visual focus on the patient during parameter changes
What is SmartPulse™ Technology?
SmartPulse™ is a tissue-sparing solution that enables sub-threshold retinal treatment by delivering laser energy in a pulsed mode to reduce collateral thermal damage while maintaining therapeutic effect.
SmartPulse™ Mode
SmartPulse™ mode provides clinicians with the capability to perform retinal photocoagulation at sub-threshold settings, offering reduced visible retinal burn and lower collateral effects compared to conventional continuous-wave photocoagulation.
History / Launch
- 1970: Lumenis (formerly Coherent) introduced the first argon laser photocoagulator in ophthalmology.
- 2016: Lumenis launched the retinal care portfolio featuring Smart532™, the green photocoagulator with SmartPulse™ capability.
Specifications / technical data
- Commercial name: Smart532™
- Brand: Lumenis
- Product type: Retinal photocoagulator
- Main technologies: Continuous-wave; SmartPulse™ sub-threshold technology
- Laser stability: Advanced laser cavity technology for improved stability
- Optics: SureSpot™ optics for defined retinal spot with low corneal power density
- Configuration: Dual-port (clinic-oriented)
- User presets: 25 programmable pre-sets
- User interface: Exclusive intuitive UI; voice confirmation mode
- Design: Compact and lightweight
- Clinical indication: Treatment of retinal diseases with sub-threshold retinal treatment capability
- Technology origin: 100% Lumenis Technology
VIDEO
Catalogs
Digital Duet & Trio
6 Pages
Other Lumenis products
Vision
Related Searches
- LUMENIS aesthetic medicine laser
- LUMENIS trolley-mounted laser
- Diode laser
- Tabletop laser
- Dermatology laser
- Nd:YAG laser
- Skin rejuvenation laser
- Class 4 laser
- Surgical laser
- Pigmented lesion treatment laser
- CO2 laser
- Acne treatment laser
- Microsecond laser
- Scar removal laser
- Nanosecond laser
- Ophthalmic biomicroscope
- Table ophthalmic biomicroscope
- Ophthalmoscope
- Ophthalmic laser
- ENT surgery laser
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.